By vgreene, 10 April, 2020 Open-Label, Non-randomized Study to Evaluate Anti-Malarial/Anti-Infective Combination Therapies in Patients With Confirmed COVID-19 Infection, NCT04339426
By vgreene, 10 April, 2020 Proposed mechanism: activity against RNA-dependent RNA polymerases; in vitro activity against arboviruses (eg, Zika)
By vgreene, 10 April, 2020 Proposed mechanism: reduces inflammatory response by inhibiting interleukin pathways via interference w/ inflammasome complex assembly; reduces cell infectivity by interrupting endocytosis via inhibition of microtubule polymerization